BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11781227)

  • 21. In vitro and in vivo plasticity of Pax5-deficient pre-B I cells.
    Rolink AG; Schaniel C; Bruno L; Melchers F
    Immunol Lett; 2002 Jun; 82(1-2):35-40. PubMed ID: 12008032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of lineage commitment during lymphocyte development.
    Staal FJ; Clevers HC
    Int Rev Immunol; 2001 Feb; 20(1):45-64. PubMed ID: 11342297
    [No Abstract]   [Full Text] [Related]  

  • 23. Early function of Pax5 (BSAP) before the pre-B cell receptor stage of B lymphopoiesis.
    Thévenin C; Nutt SL; Busslinger M
    J Exp Med; 1998 Aug; 188(4):735-44. PubMed ID: 9705955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
    Souabni A; Jochum W; Busslinger M
    Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the earliest prethymic bipotent T/NK progenitor in murine fetal liver.
    Douagi I; Colucci F; Di Santo JP; Cumano A
    Blood; 2002 Jan; 99(2):463-71. PubMed ID: 11781226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid in vivo analysis of mutant forms of the LAT adaptor using Pax5-Lat double-deficient pro-B cells.
    Ardouin L; Rolink AG; Mura AM; Gommeaux J; Melchers F; Busslinger M; Malissen M; Malissen B
    Eur J Immunol; 2005 Mar; 35(3):977-86. PubMed ID: 15719364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
    Ito M; Hiramatsu H; Kobayashi K; Suzue K; Kawahata M; Hioki K; Ueyama Y; Koyanagi Y; Sugamura K; Tsuji K; Heike T; Nakahata T
    Blood; 2002 Nov; 100(9):3175-82. PubMed ID: 12384415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors.
    Dias S; Silva H; Cumano A; Vieira P
    J Exp Med; 2005 Mar; 201(6):971-9. PubMed ID: 15767371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient Notch signaling induces NK cell potential in Pax5-deficient pro-B cells.
    Carotta S; Brady J; Wu L; Nutt SL
    Eur J Immunol; 2006 Dec; 36(12):3294-304. PubMed ID: 17111353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired hematopoiesis in mice lacking the transcription factor Sp3.
    Van Loo PF; Bouwman P; Ling KW; Middendorp S; Suske G; Grosveld F; Dzierzak E; Philipsen S; Hendriks RW
    Blood; 2003 Aug; 102(3):858-66. PubMed ID: 12676787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
    André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF
    J Immunol; 2010 Sep; 185(5):2710-20. PubMed ID: 20668220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-cell commitment: Pax5 is the deciding factor.
    Enver T
    Curr Biol; 1999 Dec 16-30; 9(24):R933-5. PubMed ID: 10607584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis.
    Nutt SL; Eberhard D; Horcher M; Rolink AG; Busslinger M
    Int Rev Immunol; 2001 Feb; 20(1):65-82. PubMed ID: 11342298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.
    Huntington ND; Legrand N; Alves NL; Jaron B; Weijer K; Plet A; Corcuff E; Mortier E; Jacques Y; Spits H; Di Santo JP
    J Exp Med; 2009 Jan; 206(1):25-34. PubMed ID: 19103877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of CD8alpha+CD11c- lineage phenotype-negative cells in the spleen as committed precursor of CD8alpha+ dendritic cells.
    Wang Y; Zhang Y; Yoneyama H; Onai N; Sato T; Matsushima K
    Blood; 2002 Jul; 100(2):569-77. PubMed ID: 12091350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concept of lymphoid versus myeloid dendritic cell lineages revisited: both CD8alpha(-) and CD8alpha(+) dendritic cells are generated from CD4(low) lymphoid-committed precursors.
    Martín P; del Hoyo GM; Anjuère F; Ruiz SR; Arias CF; Marín AR; Ardavín C
    Blood; 2000 Oct; 96(7):2511-9. PubMed ID: 11001905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pax5-deficient mice exhibit early onset osteopenia with increased osteoclast progenitors.
    Horowitz MC; Xi Y; Pflugh DL; Hesslein DG; Schatz DG; Lorenzo JA; Bothwell AL
    J Immunol; 2004 Dec; 173(11):6583-91. PubMed ID: 15557148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2.
    Spits H; Couwenberg F; Bakker AQ; Weijer K; Uittenbogaart CH
    J Exp Med; 2000 Dec; 192(12):1775-84. PubMed ID: 11120774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T-, B-, and NK-cell development.
    Schotte R; Rissoan MC; Bendriss-Vermare N; Bridon JM; Duhen T; Weijer K; Brière F; Spits H
    Blood; 2003 Feb; 101(3):1015-23. PubMed ID: 12393575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.